Thank you for attending IIR’s 7th Annual Government Programs Summit – the gold standard government programs event in the industry!
You’ve gained valuable insights and updates in addressing the tactical, strategic, compliance, legal, financial, and accounting impact of ACA expansion under all government programs such as:
|340B Program||HRSA, SNHPA, Pfizer, Vertex, Jansen, Hospira, Eli Lilly, Bristol-Myers Squibb|
|Medicare Part B & D||Sunovion, Daiichi, Actavis, Sanofi|
|Medicare & Medicaid ||Jazz Pharmaceuticals, NCPDP, NACDS, GAO, Johnson and Johnson, BIO, GAO|
|States & State Supplemental Programs||Alabama, Oregon, Utah, Novartis|
|VA, FSS & TRICARE||VA Office of Inspector General, Daiichi, Amneal|